September 9-10, 2016
UCLA Meyer & Renee Luskin Conference Center
Prostate cancer is the second most common solid organ malignancy diagnosed in men. Unlike other solid organ malignancies, the challenge in prostate cancer is to confidently identify men with moderate and high grade cancers who would most benefit from aggressive therapy. Uniquely among solid organ cancers, imaging has not been a traditional part of the workup of prostate cancer, which has relied instead on transrectal US-guided template biopsy. MR imaging has emerged as the best imaging modality to detect, grade and stage prostate cancer, especially with the introduction of PI-RADS v2. This unique one-and-a-half-day course will provide a comprehensive overview of the utility of multiparametric MR imaging for prostate cancer diagnosis. We will discuss all relevant MR imaging parameters for prostate cancer (T2, perfusion, diffusion, and spectroscopy) as well as new standardized MR reporting algorithms for prostate cancer. In conjunction with the UCLA Departments of Urology, Pathology, Nuclear Medicine, and Radiation Oncology and other world renowned speakers, we will review application of MR imaging in surgical planning for robotic prostatectomy, prostate biopsy planning, active surveillance and radiation planning. We will also discuss state-of-the-art MR targeted biopsy, focal therapy and emerging biomarkers.
Radiologists, urologists, radiation oncologists and family practitioners interested in understanding prostate MR imaging and its applications to active surveillance, biopsy planning and acquisition, surgical planning and radiation planning.
Please visit UCLA CME Website.
UCLA Radiological Sciences is affiliated with two internationally recognized, NIH-sponsored training programs that offer Masters and PhD degrees: